Topic
Private Credit Research
Within the private credit landscape, researchers emphasize the continued importance of private markets and direct lending as essential tools for diversifying portfolios amidst heightened geopolitical uncertainty and credit stress. While direct lending remains supported, analysts advocate for strict selectivity with a bias toward non-cyclical sectors and infrastructure for inflation-linked income. Credit strategies demonstrated resilience with positive returns in early 2026, though a more defensive posture is emerging through the prioritization of Relative Value and Fixed Income Relative Value sub-strategies. Solid corporate fundamentals and projected S&P 500 EPS growth of 20% support the credit outlook, even as high government deficits pose long-term risks to yields and necessitate a focus on shorter-duration fixed income. Additionally, the massive expansion in AI-related demand, with a projected $1.7 trillion TAM by 2030, and the evolution of biotech into a compounding asset class are creating new long-term investment opportunities for credit providers. Collectively, these insights suggest a research direction focused on resilient, innovation-driven sectors to navigate a goldilocks environment disrupted by macro volatility.
4639 reports available
All reports
Page 72 of 194
Sana Biotechnology Annual Global Healthcare Conference Key Takeaways
Goldman Sachs · Jun 10, 2026
US Equities Mid-Day Color
Goldman Sachs · Jun 10, 2026
US Equities Color: Tech Unwind
Goldman Sachs & Co. LLC · Jun 10, 2026
TMT Specialist Sales Daily Wrap
Goldman Sachs · Jun 10, 2026
China Equity Strategy
HSBC Qianhai Securities Limited · Jun 10, 2026
GS Morning
Goldman Sachs · Jun 10, 2026
US Market Intelligence Morning Briefing
J.P. Morgan · Jun 10, 2026
U.S. Analyst Focus List
J.P. Morgan · Jun 10, 2026
Vertex Pharmaceuticals Inc. Key Takeaways
Goldman Sachs · Jun 10, 2026
Investors' Resilient Risk Sentiment
Crédit Agricole Corporate and Investment Bank · Jun 10, 2026
Zealand Pharma 47th Annual Global Healthcare Conference Key Takeaways
Goldman Sachs · Jun 10, 2026
Global Healthcare Annual Global Healthcare Conference Notes From Investment Banker Panel
Goldman Sachs · Jun 10, 2026
Middle East Daily
MUFG · Jun 10, 2026
Gilead Sciences Inc. (GILD): 47th Annual Global Healthcare Conference Key Takeaways
Goldman Sachs · Jun 10, 2026
European Economics And Rates Strategy
RBC Capital Markets · Jun 10, 2026
The Global Point
Citi · Jun 10, 2026
Americas Morning Research Summary
Barclays · Jun 10, 2026
Midday Market Intelligence
Goldman Sachs · Jun 10, 2026
Global Macro Strategy Correlation Corner Expressions For US Exceptionalism
Citi · Jun 10, 2026
Europe Equity Research Today's Morning Meeting
J.P. Morgan · Jun 10, 2026
Americas Small Cap Research Summary
Barclays · Jun 10, 2026
US Equity Unwind Repeats Friday's Playbook
Citi · Jun 10, 2026
EMEA Special Situations Specialist Commentary
J.P. Morgan · Jun 10, 2026
Ardent Health Inc. Key Takeaways
Goldman Sachs · Jun 10, 2026